IBDEI0EO ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19800,0)
 ;;=V10.47^^133^1135^43
 ;;^UTILITY(U,$J,358.3,19800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19800,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,19800,1,5,0)
 ;;=5^HX-TESTICULAR MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19800,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,19801,0)
 ;;=V10.48^^133^1135^48
 ;;^UTILITY(U,$J,358.3,19801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19801,1,4,0)
 ;;=4^V10.48
 ;;^UTILITY(U,$J,358.3,19801,1,5,0)
 ;;=5^PSNL HX MAL NEOPL-EPIDID
 ;;^UTILITY(U,$J,358.3,19801,2)
 ;;=^321226
 ;;^UTILITY(U,$J,358.3,19802,0)
 ;;=V10.49^^133^1135^33
 ;;^UTILITY(U,$J,358.3,19802,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19802,1,4,0)
 ;;=4^V10.49
 ;;^UTILITY(U,$J,358.3,19802,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NEC
 ;;^UTILITY(U,$J,358.3,19802,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,19803,0)
 ;;=V10.50^^133^1135^46
 ;;^UTILITY(U,$J,358.3,19803,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19803,1,4,0)
 ;;=4^V10.50
 ;;^UTILITY(U,$J,358.3,19803,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,19803,2)
 ;;=^295227
 ;;^UTILITY(U,$J,358.3,19804,0)
 ;;=V10.51^^133^1135^1
 ;;^UTILITY(U,$J,358.3,19804,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19804,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,19804,1,5,0)
 ;;=5^HX OF BLADDER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19804,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,19805,0)
 ;;=V10.52^^133^1135^10
 ;;^UTILITY(U,$J,358.3,19805,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19805,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,19805,1,5,0)
 ;;=5^HX OF KIDNEY MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19805,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,19806,0)
 ;;=V10.53^^133^1135^15
 ;;^UTILITY(U,$J,358.3,19806,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19806,1,4,0)
 ;;=4^V10.53
 ;;^UTILITY(U,$J,358.3,19806,1,5,0)
 ;;=5^HX OF MAL NEOPLASM,RENAL PELVIS
 ;;^UTILITY(U,$J,358.3,19806,2)
 ;;=^323624
 ;;^UTILITY(U,$J,358.3,19807,0)
 ;;=V10.59^^133^1135^45
 ;;^UTILITY(U,$J,358.3,19807,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19807,1,4,0)
 ;;=4^V10.59
 ;;^UTILITY(U,$J,358.3,19807,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NEC
 ;;^UTILITY(U,$J,358.3,19807,2)
 ;;=^295230
 ;;^UTILITY(U,$J,358.3,19808,0)
 ;;=V10.60^^133^1135^12
 ;;^UTILITY(U,$J,358.3,19808,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19808,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,19808,1,5,0)
 ;;=5^HX OF LEUKEMIA NOS
 ;;^UTILITY(U,$J,358.3,19808,2)
 ;;=^295231
 ;;^UTILITY(U,$J,358.3,19809,0)
 ;;=V10.61^^133^1135^14
 ;;^UTILITY(U,$J,358.3,19809,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19809,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,19809,1,5,0)
 ;;=5^HX OF LYMPHOID LEUKEMIA
 ;;^UTILITY(U,$J,358.3,19809,2)
 ;;=^295232
 ;;^UTILITY(U,$J,358.3,19810,0)
 ;;=V10.62^^133^1135^18
 ;;^UTILITY(U,$J,358.3,19810,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19810,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,19810,1,5,0)
 ;;=5^HX OF MYELOID LEUKEMIA
 ;;^UTILITY(U,$J,358.3,19810,2)
 ;;=^295233
 ;;^UTILITY(U,$J,358.3,19811,0)
 ;;=V10.63^^133^1135^17
 ;;^UTILITY(U,$J,358.3,19811,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19811,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,19811,1,5,0)
 ;;=5^HX OF MONOCYTIC LEUKEMIA
 ;;^UTILITY(U,$J,358.3,19811,2)
 ;;=^295234
 ;;^UTILITY(U,$J,358.3,19812,0)
 ;;=V10.69^^133^1135^11
 ;;^UTILITY(U,$J,358.3,19812,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19812,1,4,0)
 ;;=4^V10.69
 ;;^UTILITY(U,$J,358.3,19812,1,5,0)
 ;;=5^HX OF LEUKEMIA NEC
 ;;^UTILITY(U,$J,358.3,19812,2)
 ;;=^295235
 ;;^UTILITY(U,$J,358.3,19813,0)
 ;;=V10.71^^133^1135^32
 ;;^UTILITY(U,$J,358.3,19813,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19813,1,4,0)
 ;;=4^V10.71
 ;;^UTILITY(U,$J,358.3,19813,1,5,0)
 ;;=5^HX-LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,19813,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,19814,0)
 ;;=V10.72^^133^1135^28
 ;;^UTILITY(U,$J,358.3,19814,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19814,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,19814,1,5,0)
 ;;=5^HX-HODGKIN'S DISEASE
 ;;^UTILITY(U,$J,358.3,19814,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,19815,0)
 ;;=V10.79^^133^1135^31
 ;;^UTILITY(U,$J,358.3,19815,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19815,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,19815,1,5,0)
 ;;=5^HX-LYMPHATIC MALIGN NEC
 ;;^UTILITY(U,$J,358.3,19815,2)
 ;;=^295238
 ;;^UTILITY(U,$J,358.3,19816,0)
 ;;=V10.81^^133^1135^2
 ;;^UTILITY(U,$J,358.3,19816,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19816,1,4,0)
 ;;=4^V10.81
 ;;^UTILITY(U,$J,358.3,19816,1,5,0)
 ;;=5^HX OF BONE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19816,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,19817,0)
 ;;=V10.82^^133^1135^35
 ;;^UTILITY(U,$J,358.3,19817,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19817,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,19817,1,5,0)
 ;;=5^HX-MALIG SKIN MELANOMA
 ;;^UTILITY(U,$J,358.3,19817,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,19818,0)
 ;;=V10.83^^133^1135^42
 ;;^UTILITY(U,$J,358.3,19818,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19818,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,19818,1,5,0)
 ;;=5^HX-SKIN MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,19818,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,19819,0)
 ;;=V10.84^^133^1135^6
 ;;^UTILITY(U,$J,358.3,19819,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19819,1,4,0)
 ;;=4^V10.84
 ;;^UTILITY(U,$J,358.3,19819,1,5,0)
 ;;=5^HX OF EYE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19819,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,19820,0)
 ;;=V10.85^^133^1135^3
 ;;^UTILITY(U,$J,358.3,19820,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19820,1,4,0)
 ;;=4^V10.85
 ;;^UTILITY(U,$J,358.3,19820,1,5,0)
 ;;=5^HX OF BRAIN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19820,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,19821,0)
 ;;=V10.86^^133^1135^36
 ;;^UTILITY(U,$J,358.3,19821,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19821,1,4,0)
 ;;=4^V10.86
 ;;^UTILITY(U,$J,358.3,19821,1,5,0)
 ;;=5^HX-MALIGN NERVE SYST NEC
 ;;^UTILITY(U,$J,358.3,19821,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,19822,0)
 ;;=V10.87^^133^1135^20
 ;;^UTILITY(U,$J,358.3,19822,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19822,1,4,0)
 ;;=4^V10.87
 ;;^UTILITY(U,$J,358.3,19822,1,5,0)
 ;;=5^HX OF THYROID MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19822,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,19823,0)
 ;;=V10.88^^133^1135^24
 ;;^UTILITY(U,$J,358.3,19823,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19823,1,4,0)
 ;;=4^V10.88
 ;;^UTILITY(U,$J,358.3,19823,1,5,0)
 ;;=5^HX-ENDOCRINE MALIGN NEC
 ;;^UTILITY(U,$J,358.3,19823,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,19824,0)
 ;;=V10.89^^133^1135^16
 ;;^UTILITY(U,$J,358.3,19824,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19824,1,4,0)
 ;;=4^V10.89
 ;;^UTILITY(U,$J,358.3,19824,1,5,0)
 ;;=5^HX OF MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,19824,2)
 ;;=^295247
 ;;^UTILITY(U,$J,358.3,19825,0)
 ;;=V45.71^^133^1136^7
 ;;^UTILITY(U,$J,358.3,19825,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19825,1,4,0)
 ;;=4^V45.71
 ;;^UTILITY(U,$J,358.3,19825,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF BREAST
 ;;^UTILITY(U,$J,358.3,19825,2)
 ;;=^336882
 ;;^UTILITY(U,$J,358.3,19826,0)
 ;;=V45.72^^133^1136^6
 ;;^UTILITY(U,$J,358.3,19826,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19826,1,4,0)
 ;;=4^V45.72
 ;;^UTILITY(U,$J,358.3,19826,1,5,0)
 ;;=5^ACQ. ABS. OF INTESTINE (LG,SM)
 ;;^UTILITY(U,$J,358.3,19826,2)
 ;;=^317959
 ;;^UTILITY(U,$J,358.3,19827,0)
 ;;=V45.73^^133^1136^8
 ;;^UTILITY(U,$J,358.3,19827,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19827,1,4,0)
 ;;=4^V45.73
 ;;^UTILITY(U,$J,358.3,19827,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF KIDNEY
 ;;^UTILITY(U,$J,358.3,19827,2)
 ;;=^317962
 ;;^UTILITY(U,$J,358.3,19828,0)
 ;;=V45.74^^133^1136^4
 ;;^UTILITY(U,$J,358.3,19828,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19828,1,4,0)
 ;;=4^V45.74
 ;;^UTILITY(U,$J,358.3,19828,1,5,0)
 ;;=5^ACQ ABSENCE ORG,URINARY TRACT
 ;;^UTILITY(U,$J,358.3,19828,2)
 ;;=^322063
 ;;^UTILITY(U,$J,358.3,19829,0)
 ;;=V45.75^^133^1136^3
 ;;^UTILITY(U,$J,358.3,19829,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19829,1,4,0)
 ;;=4^V45.75
 ;;^UTILITY(U,$J,358.3,19829,1,5,0)
 ;;=5^ACQ ABSENCE ORG,STOMACH
 ;;^UTILITY(U,$J,358.3,19829,2)
 ;;=^322065
 ;;^UTILITY(U,$J,358.3,19830,0)
 ;;=V45.76^^133^1136^2
 ;;^UTILITY(U,$J,358.3,19830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19830,1,4,0)
 ;;=4^V45.76
 ;;^UTILITY(U,$J,358.3,19830,1,5,0)
 ;;=5^ACQ ABSENCE ORG,LUNG
 ;;^UTILITY(U,$J,358.3,19830,2)
 ;;=^322066
 ;;^UTILITY(U,$J,358.3,19831,0)
 ;;=V45.77^^133^1136^1
 ;;^UTILITY(U,$J,358.3,19831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19831,1,4,0)
 ;;=4^V45.77
 ;;^UTILITY(U,$J,358.3,19831,1,5,0)
 ;;=5^ACQ ABSENCE ORG,GENITALS
 ;;^UTILITY(U,$J,358.3,19831,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,19832,0)
 ;;=V45.78^^133^1136^5
 ;;^UTILITY(U,$J,358.3,19832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19832,1,4,0)
 ;;=4^V45.78
 ;;^UTILITY(U,$J,358.3,19832,1,5,0)
 ;;=5^ACQ ABSENCE ORGAN,EYE
 ;;^UTILITY(U,$J,358.3,19832,2)
 ;;=^322068
 ;;^UTILITY(U,$J,358.3,19833,0)
 ;;=V45.79^^133^1136^9
 ;;^UTILITY(U,$J,358.3,19833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19833,1,4,0)
 ;;=4^V45.79
 ;;^UTILITY(U,$J,358.3,19833,1,5,0)
 ;;=5^OTH ACQ ABSENCE ORGAN
 ;;^UTILITY(U,$J,358.3,19833,2)
 ;;=^322069
 ;;^UTILITY(U,$J,358.3,19834,0)
 ;;=V65.0^^133^1137^4
 ;;^UTILITY(U,$J,358.3,19834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19834,1,4,0)
 ;;=4^V65.0
 ;;^UTILITY(U,$J,358.3,19834,1,5,0)
 ;;=5^HEALTHY PERSON W SICK
 ;;^UTILITY(U,$J,358.3,19834,2)
 ;;=^295561
 ;;^UTILITY(U,$J,358.3,19835,0)
 ;;=V65.19^^133^1137^9
 ;;^UTILITY(U,$J,358.3,19835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19835,1,4,0)
 ;;=4^V65.19
 ;;^UTILITY(U,$J,358.3,19835,1,5,0)
 ;;=5^PERSON CONSULT FOR ANOTH
 ;;^UTILITY(U,$J,358.3,19835,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,19836,0)
 ;;=V65.2^^133^1137^10
 ;;^UTILITY(U,$J,358.3,19836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19836,1,4,0)
 ;;=4^V65.2
 ;;^UTILITY(U,$J,358.3,19836,1,5,0)
 ;;=5^PERSON FEIGNING ILLNESS
